Statement Of Changes In Equity [Abstract]

Captor Therapeutics S.A. - Filing #6226332

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
39 882 297 PLN
2 968 461 PLN
141 143 534 PLN
141 143 534 PLN
98 153 259 PLN
0 PLN
139 516 PLN
89 434 346 PLN
53 518 617 PLN
0 PLN
49 830 702 PLN
0 PLN
147 092 666 PLN
136 000 PLN
136 000 PLN
143 404 751 PLN
4 003 703 PLN
0 PLN
89 434 346 PLN
4 003 703 PLN
147 092 666 PLN
143 404 751 PLN
0 PLN
3 687 916 PLN
0 PLN
0 PLN
3 687 916 PLN
3 687 916 PLN
89 433 646 PLN
136 700 PLN
79 129 831 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
14 444 015 PLN
0 PLN
0 PLN
4 003 500 PLN
0 PLN
89 433 646 PLN
136 700 PLN
4 003 500 PLN
14 444 015 PLN
79 129 831 PLN
0 PLN
79 129 831 PLN
79 129 831 PLN
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
0 PLN
0 PLN
13 636 319 PLN
0 PLN
0 PLN
13 636 319 PLN
13 636 319 PLN
67 962 632 PLN
67 962 632 PLN
0 PLN
0 PLN
0 PLN
0 PLN
67 962 632 PLN
Other comprehensive income
0 PLN
13 507 PLN
13 507 PLN
0 PLN
0 PLN
13 507 PLN
0 PLN
203 PLN
0 PLN
203 PLN
0 PLN
0 PLN
0 PLN
203 PLN
Comprehensive income
0 PLN
13 507 PLN
13 622 812 PLN
0 PLN
0 PLN
13 622 812 PLN
13 636 319 PLN
67 962 835 PLN
67 962 632 PLN
203 PLN
0 PLN
0 PLN
0 PLN
67 962 835 PLN
Issue of equity
0 PLN
3 883 749 PLN
4 838 680 PLN
8 718 913 PLN
3 516 PLN
4 838 680 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
Increase (decrease) through treasury share transactions, equity
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
700 PLN
0 PLN
700 PLN
0 PLN
Increase (decrease) through share-based payment transactions, equity
0 PLN
2 835 000 PLN
2 835 000 PLN
0 PLN
0 PLN
2 835 000 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
0 PLN
Increase (decrease) in equity
0 PLN
1 035 242 PLN
5 949 132 PLN
8 718 913 PLN
3 516 PLN
5 949 132 PLN
13 636 319 PLN
67 962 835 PLN
67 962 632 PLN
203 PLN
700 PLN
0 PLN
700 PLN
67 962 835 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.